Scarica l'app Stockscreener
87.20
0.73%
0.62
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$86.58
Aprire:
$86.9
Volume 24 ore:
2.02M
Relative Volume:
0.26
Capitalizzazione di mercato:
$111.94B
Reddito:
$35.48B
Utile/perdita netta:
$4.64B
Rapporto P/E:
24.34
EPS:
3.582
Flusso di cassa netto:
$5.41B
1 W Prestazione:
+0.00%
1M Prestazione:
-9.76%
6M Prestazione:
-7.52%
1 anno Prestazione:
-1.55%
Intervallo 1D:
$86.34
$87.80
Intervallo di 1 settimana:
$85.78
$87.80
Portata 52W:
$79.55
$106.33
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
87.19 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
ABT
Abbott Laboratories
|
104.78 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
326.70 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
BSX
Boston Scientific Corp
|
69.15 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.11 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-13 | Ripresa | Barclays | Overweight |
| 2026-02-09 | Aggiornamento | Needham | Hold → Buy |
| 2026-02-03 | Ripresa | Citigroup | Buy |
| 2026-01-30 | Ripresa | Wells Fargo | Overweight |
| 2026-01-06 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2025-06-30 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Reiterato | Oppenheimer | Perform |
| 2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2024-08-14 | Downgrade | Stifel | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Downgrade | UBS | Buy → Sell |
| 2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
| 2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-10 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
| 2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
| 2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Sell |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Medtronic (MDT) Revises Earnings Outlook Amid MiniMed IPO Impact - GuruFocus
Medtronic inks distribution deal for Merit Medical’s basivertebral ablation system - Medical Device Network
Medtronic cuts earnings outlook on MiniMed updates (MDT:NYSE) - Seeking Alpha
Medtronic (MDT) Announces FDA Approval for Expanded Indication of OmniaSecure - Insider Monkey
Medtronic plc stock faces pressure amid cardiovascular device scrutiny and slowing growth in Q1 2026 - AD HOC NEWS
Medtronic plc Files Form 8-K Disclosing Senior Notes and Company Information (March 24, 2026) - Minichart
Medtronic plc stock faces pressure after cutting fiscal 2026 guidance on $157 million one-time charg - AD HOC NEWS
Medtronic cuts annual forecast on $157 million one-time charge - marketscreener.com
Medtronic (MDT) Adjusts EPS Forecast Following MiniMed Developme - GuruFocus
Medtronic Cuts Fiscal 2026 EPS Outlook After MiniMed Charges - TipRanks
Medtronic (MDT) cuts FY26 EPS outlook as MiniMed Flex funding and IPO dilute earnings - Stock Titan
Medtronic to distribute Merit Medical’s low back pain treatment - MedTech Dive
Medtronic (MDT) Partners with Merit Medical to Distribute Innova - GuruFocus
Medtronic partners with Merit Medical to distribute back pain device - Investing.com
Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain - PR Newswire
Medtronic’s OmniaSecure defib lead nets another FDA approval - Medical Device Network
Medtronic plc declares $0.71 dividend - MSN
Medtronic PLC stock outperforms competitors on strong trading day - MarketWatch
Medtronic's (NYSE:MDT) Global Reach Shapes Healthcare Innovation Across The S&P 500 - Kalkine Media
Medtronic (MDT) Gains FDA Approval for Expanded Use of OmniaSecu - GuruFocus
Medtronic gets FDA nod for defibrillation lead in heart pacing - Investing.com
Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing - Medtronic
Trend Recap: What is the dividend yield of Medtronic plcChart Signals & Trade Opportunity Analysis Reports - baoquankhu1.vn
Stop Loss: Is Medtronic plc a top pick in the sectorJobs Report & Low Risk Investment Opportunities - baoquankhu1.vn
Medtronic (NYSE:MDT) Strengthens Neurovascular Portfolio And Russell 1000 Market Appeal - Kalkine Media
Medtronic Plc Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 - The Motley Fool
Medtronic (MDT) down 11.5% since last earnings report: Can it rebound? - MSN
FDA Clears MiniMed Flex Pump As Medtronic Valuation Debate Continues - Yahoo Finance
Medtronic (MDT) Down 11.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance Australia
Medtronic PLC stock underperforms Wednesday when compared to competitors - MarketWatch
MiniMed gets FDA nod for smaller insulin pump - MedTech Dive
Medtronic Named One of the 2026 World’s Most Ethical Companies® - CSRwire
PFA startup Field Medical appoints Mark Turco as CEO - MedTech Dive
Kimelman & Baird LLC Buys 29,978 Shares of Medtronic PLC $MDT - MarketBeat
Danske Bank A S Invests $71.89 Million in Medtronic PLC $MDT - MarketBeat
14,290 Shares in Medtronic PLC $MDT Purchased by Stance Capital LLC - MarketBeat
Medtronic (MDT) strengthens neurovascular platform with Scientia Vascular purchase - MSN
Medtronic (MDT) Strengthens Neurovascular Platform with Scientia Vascular Purchase - Insider Monkey
MDT PE Ratio & Valuation, Is MDT Overvalued - Intellectia AI
Medtronic PLC $MDT Stock Holdings Trimmed by Mairs & Power Inc. - MarketBeat
Medtronic: Snatch Up This Dividend Aristocrat Bargain Now (NYSE:MDT) - Seeking Alpha
Lighthouse Investment Partners LLC Has $4.92 Million Stock Position in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Gotham Asset Management LLC - MarketBeat
Medtronic plc Stock (ISIN: IE00BTN1Y115) Gains on MiniMed IPO Momentum and Neurovascular Acquisition - AD HOC NEWS
Smart Hospitals Market Is Booming So Rapidly | Medtronic Plc, Koninklijke Philips N.V., and GE Healthcare - openPR.com
Medtronic Seeks To Ax 'Extreme Outlier' $382M Antitrust Loss - Law360
Medtronic : leaders to speak on artificial intelligence and digital twin technology at upcoming NVIDIA GTC - marketscreener.com
Medtronic Plc Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Iron Triangle Partners LP Grows Stock Position in Medtronic PLC $MDT - MarketBeat
Surgical Equipment Market Is Booming So Rapidly | Medtronic plc, - openPR.com
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.14%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):